Tandem Diabetes Care, Inc. (TNDM)

NasdaqGM • Currently down 0.01 (-0.06%) in today's trading session

1 member of Congress has disclosed 2 trades in Tandem Diabetes Care, Inc. (TNDM) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 3 March 2026. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).

Tandem Diabetes Care, Inc. is currently trading at $16.90, positioned at 35% of its 52-week range ($9.98 – $29.65).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$16.90
24h Change
-0.01 (-0.06%)
52 Week Range
$9.98—$29.65
View on NASDAQ

Tandem Diabetes Care, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TNDM

Select to highlight on chart
2 transactions
Compliance: 100%
Gilbert Cisneros3 Mar 20267 Apr 2026PurchaseStock$1,001 - $15,000-33.02%
Gilbert Cisneros4 Mar 20257 Apr 2025PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.16B

Volume

1.14M

Beta

1.58

P/E Ratio

-15.36

Fundamentals

EPS

$-1.10

Div. Yield

—

Open

$16.93

Day Range

$16.14 — $17.09

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
John F. Sheridan
IPO Date
2013-11-14
Website
www.tandemdiabetes.com

Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system,...

Earnings

Next Report

Q2 2026

6 Aug

EPS Est.

$-0.34

Rev. Est.

$255M

Days Until

14

Recent Quarters

Q1 20267 May
EPS$-0.30
Beat 34.8%
Q4 202519 Feb
EPS$-0.01
Beat 80.0%
Q3 20256 Nov
EPS$-0.31
Beat 0.0%
Q2 20256 Aug
EPS$-0.48
Miss 20.0%
Q1 202530 Apr
EPS$-0.67
Miss 11.7%
Q4 202426 Feb
EPS$-0.44
Miss 76.0%
Q3 20246 Nov
EPS$-0.36
Beat 16.3%
Q2 20241 Aug
EPS$-0.47
Beat 13.0%
Q1 20242 May
EPS$-0.63
Beat 21.3%
Q4 202321 Feb
EPS$-0.27
Miss 17.4%
Q3 20231 Nov
EPS$-0.38
Miss 8.6%
Q2 20233 Aug
EPS$-0.30
Beat 44.4%
Q1 20233 May
EPS$-0.63
Miss 12.5%
Q4 202222 Feb
EPS$-0.01
Miss 338.6%
Q3 20222 Nov
EPS$-0.27
Miss 455.3%
Q2 20223 Aug
EPS$-0.24
Miss 1460.5%
Q1 20224 May
EPS$-0.23
Miss 228.6%
Q4 202122 Feb
EPS$0.16
Miss 23.8%
Q3 20213 Nov
EPS$0.09
Beat 50.0%
Q2 20214 Aug
EPS$0.06
Beat 175.0%
Q1 20215 May
EPS$-0.07
Beat 53.3%
Q4 202024 Feb
EPS$0.22
Beat 83.3%
Q3 20205 Nov
EPS$-0.09
Miss 12.5%
Q2 202030 Jul
EPS$-0.19
Beat 20.8%
Q1 202030 Apr
EPS$-0.22
Miss 22.2%
Q4 201924 Feb
EPS$0.04
Beat 180.0%
Q3 20194 Nov
EPS$-0.13
Beat 35.0%
Q2 20191 Aug
EPS$-0.03
Beat 87.0%
Q1 201930 Apr
EPS$-0.18
Beat 35.7%
Q4 201826 Feb
EPS$0.02
Beat 109.1%
Q3 20181 Nov
EPS$-0.30
Beat 11.8%
Q2 201830 Jul
EPS$-0.34
Beat 2.9%
Q1 201826 Apr
EPS$-1.03
Miss 74.6%
Q4 20171 Mar
EPS$-1.23
Beat 3.9%
Q3 201726 Oct
EPS$-3.09
Beat 17.4%
Q2 201727 Jul
EPS$-4.40
Beat 8.3%
Q1 201727 Apr
EPS$-7.50
Miss 13.6%
Q4 20168 Mar
EPS$-4.80
Beat 23.8%
Q3 20161 Nov
EPS$-9.70
Miss 64.4%
Q2 201628 Jul
EPS$-6.00
Beat 7.7%
Q1 201628 Apr
EPS$-6.80
Beat 1.4%
Q4 201524 Feb
EPS$-4.00
Beat 23.1%
Q3 201529 Oct
EPS$-6.50
Beat 15.6%
Q2 201530 Jul
EPS$-6.50
Beat 8.4%
Q1 201530 Apr
EPS$-8.30
Miss 7.8%
Q4 201424 Feb
EPS$-7.80
Beat 3.7%
Q3 20146 Nov
EPS$-8.50
Miss 3.7%
Q2 201431 Jul
EPS$-8.30
Beat 7.8%
Q1 20146 May
EPS$-9.60
Miss 39.1%
Q4 20136 Mar
EPS$-16.00
Miss 22.1%
Q4 20136 Mar
EPS$-10.30
Q1 201330 Jun
EPS$-12.20
Q4 201231 Mar
EPS$-8.90
Q3 201231 Dec
EPS$-6.82
Q2 201230 Sept
EPS$-5.99

No dividend data available for this stock.

Stock Splits

Split History

10 Oct 2017Reverse Split
Ratio1:10

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AAPL

Apple Inc.

22
$321.66-4.23 (-1.30%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

WBI

WaterBridge Infrastructure LLC

17
$35.54-0.67 (-1.85%)
Energy
Held by same politician
1 politician
View Stock

SPY

State Street SPDR S&P 500 ETF Trust

17
$738.18-9.23 (-1.23%)
Financial Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about TNDM

Which members of Congress have traded TNDM?
1 member of Congress has disclosed 2 trade in Tandem Diabetes Care, Inc. (TNDM) under the STOCK Act: Gilbert Cisneros.
When was TNDM most recently disclosed by Congress?
The most recent TNDM disclosure was a purchase by Gilbert Cisneros on 3 March 2026.
What is the total disclosed congressional trading volume for TNDM?
Members of Congress have disclosed approximately $16K in TNDM purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in TNDM?
This TNDM page updates as soon as new STOCK Act disclosures are filed for Tandem Diabetes Care, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.